HJMC
AGIO icon

Hellman Jordan Management Company’s Agios Pharmaceuticals AGIO Stock Holding History

Hellman Jordan Management Company’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-40,000
Closed -$2.45M – 51
2014
Q3 		$2.45M Buy
+40,000
New +$1.72M 0.47% 41

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CGT
Capital Guardian Trust Los Angeles, California $7.42B AUM 13.6% 1-Year Est. Return

Hellman Jordan Management Company's AGIO Position: Q4 2014 in Review

Hellman Jordan Management Company sold out of Agios Pharmaceuticals (AGIO) in Q4 2014, closing a stake of 40,000 shares — an estimated $2.45M sold.

Hellman Jordan Management Company first reported a position in AGIO in Q3 2014 and held it in 1 quarter. The position peaked at $2.45M in Q3 2014. 142 funds tracked by Wall St. Rank hold AGIO as of Q4 2014.

  • Hellman Jordan Management Company reported no remaining Agios Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Hellman Jordan Management Company sold 40,000 Agios Pharmaceuticals shares in Q4 2014, an estimated $2.45M.
  • Hellman Jordan Management Company first reported a position in Agios Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Hellman Jordan Management Company's Agios Pharmaceuticals position peaked at $2.45M in Q3 2014.
  • 142 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2014.

Based on Hellman Jordan Management Company's 13F filing for Q4 2014, filed 30 Jan 2015.